Contract

Newmedica

  • NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board

F03: Contract award notice

Notice identifier: 2024/S 000-035842

Procurement identifier (OCID): ocds-h6vhtk-04b429

Published 5 November 2024, 4:39pm



Section one: Contracting authority

one.1) Name and addresses

NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board

Floor 2, North Wing, 100 Temple Street

BRISTOL

BS1 6AG

Email

bnssg.acutecontracting@nhs.net

Country

United Kingdom

Region code

UKK11 - Bristol, City of

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://bnssg.icb.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Newmedica

Reference number

BNSSG_627_Newmedica_2024-2026_A

two.1.2) Main CPV code

  • 85121281 - Ophthalmologist services

two.1.3) Type of contract

Services

two.1.4) Short description

The service will provide routine elective secondary care services for patients in the following specialities

• Ophthalmology

• Potential for community Age-related Macular Degeneration/Glaucoma monitoring where specifically agreed in advance by the commissioner

• Diagnostics procedures forming part of an agreed pathway

• Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner

• Cataract, Yag and Oculoplastics

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £0.1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKK1 - Gloucestershire, Wiltshire and Bristol/Bath area

two.2.4) Description of the procurement

The service will provide routine elective secondary care services for patients in the following specialities

• Ophthalmology

• Potential for community Age-related Macular Degeneration/Glaucoma monitoring where specifically agreed in advance by the commissioner

• Diagnostics procedures forming part of an agreed pathway

• Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner

The services will include, where appropriate;

• Pre-treatment e.g., referral processes; triage/clinical assessment; diagnostics; consultation; pre-treatment assessment and / or work up.

• Treatment e.g., outpatient/ambulatory/inpatient treatment; joint assessments.

• Discharge e.g., expected physical, self-care, psychological capabilities prior to discharge.

• Follow up e.g., specialist support post discharge, referrals to other general or specialist services such as GP or District Nurse, self-care requirements for a period up to and including 14 days post discharge.

Yag laser capsulotomy is a simple, safe laser treatment to improve eyesight if some fogging recurs after cataract surgery because of lense clouding.

Oculoplastics covers conditions affecting displacement of the eyelids, tumours of the eyelids and surrounding areas, lacrimal gland conditions, failure of the tear drainage system, orbital tumours and thyroid eye disease.

The award has been made following Direct Award Process B..

This is an activity-based contract with no guaranteed value.

The contract has been awarded for the period 01/04/2024 - 31/03/2026 with no provision for extension included

two.2.5) Award criteria

Quality criterion - Name: Patient Choice / Weighting: 100

Price - Weighting: 0

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

The procurement has been conducted in line with Right to Choose requirements.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

BNSSG_627_Newmedica_2024-2026_A

Title

Newmedica

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

1 April 2024

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

New Medical Systems Ltd trading as Newmedica (ODS ACG01)

CentralPoint,45 Beech Street

London

EC2Y 8AD

Country

United Kingdom

NUTS code
  • UKI - London
Companies House

06211226

The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £0.01

Total value of the contract/lot: £0.01


Section six. Complementary information

six.3) Additional information

Award Decision made by - Niall Mitchell, Deputy head of Acute Contracts (Acute and Mental Health)

No conflicts of interest were identified or declared during the process.

South, Central and West Commissioning Support were only requested to publish the notice on behalf of the BNSSG ICB.

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

six.4) Procedures for review

six.4.1) Review body

Bristol, North Somerset and South Gloucestershire ICB

Bristol

Country

United Kingdom